Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1809629 10.3389/fphar.2026.1809629 Correction Correction: Pharmacokinetics and nephrotoxicity of cisplatin modulated by combination therapy with brusatol Guo et al. 10.3389/fphar.2026.1809629 Guo Nan 1 † Conceptualization Funding acquisition Writing – review and editing Methodology Validation Formal Analysis Data curation Zhang Yahui 1 † Data curation Methodology Validation Writing – original draft Yuan Guiyan 2 Writing – review and editing Data curation Investigation Zhang Xiaoran 3 Writing – review and editing Investigation Zhang Wen 1 * Supervision Conceptualization Writing – review and editing Project administration Funding acquisition Wen Qing 3 * Project administration Writing – review and editing Supervision Funding acquisition Conceptualization Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China Phase I Drug Clinical Trial Center, Qilu Hospital of Shandong University, Jinan, China Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China Correspondence: Qing Wen, wenq0619@126.com; Wen Zhang, zhangwen_jyk@126.com

These authors have contributed equally to this work

 02 03 2026 2026 17 1809629 12 02 2026 17 02 2026 Copyright © 2026 Guo, Zhang, Yuan, Zhang, Zhang and Wen. 2026 Guo, Zhang, Yuan, Zhang, Zhang and Wen https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Correction on Pharmacokinetics and nephrotoxicity of cisplatin modulated by combination therapy with brusatol by Guo N, Zhang Y, Yuan G, Zhang X, Zhang W and Wen Q (2026). Front. Pharmacol. 17:1708101. doi: 10.3389/fphar.2026.1708101 brusatol cisplatin drug interaction HPLC-MS nephrotoxicity section-at-acceptance Ethnopharmacology

There was a mistake in Figure 2 as published. The middle panel of the figure was missing the caption ‘Kidney’. The corrected Figure 2 appears below.

Mean concentration-time curves for CDDP (10 mg/kg) in plasma, kidneys, and lungs after intraperitoneal injection in mice in the presence or absence of treatment with brusatol (2 mg/kg) (mean ± SD, n = 5).

Three line graphs compare concentration of CDDP and CDDP plus Bru over time in plasma, kidney, and lung. Concentrations decrease over 24 hours in all tissues, with error bars shown.

The original article has been updated.

Generative AI statement

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

 Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Edited and Reviewed by: Javier Echeverria, University of Santiago, Chile